Variant · Snv
CFH NM_000186.4(CFH):c.*98C>T
CI-VAR-00050173Explore in graph →NM_000186.4:c.*98C>TClinVar 294528 rs35742764
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 294528 | Benign | criteria provided, multiple submitters, no conflicts | 2 | Age related macular degeneration 4; CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II; Basal laminar drusen; Hemolytic uremic syndrome, atypical, susceptibility to, 1; Factor H deficiency; Ovarian serous cystadenocarcinoma; Uterine corpus endometrial carcinoma; Cervical cancer | germline | 5 | Apr 11, 2023 | clinvar |